MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

MAIA Biotechnology (MAIA) announced updated data from its THIO-101 pivotal Phase 2 clinical trial evaluating its lead clinical candidate, THIO, ...

A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC) options could extend overall survival (OS) to 16.9 months according to ...

CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...

Northern Tool + Equipment is bringing the high-octane excitement of Monster Jam® to the Little Rock community. On Thursday, February 20, customers will have the chance to experience the thrill-seeking ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Utilizing new data from the Yardi® Matrix affordable housing database, the latest Yardi Matrix report on affordable housing explores the sector's current state of deliveries and ...

After hours: 7:50:02 p.m. EST ...

Kingswood Wealth Advisors LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 33.6% in the fourth quarter, according to the company in its most recent ...

This week, I'm visiting Colorado to see its thriving biotechnology industry and meet with local leaders. Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average ...